NYSE · DOCS
Healthcare · Medical - Healthcare Information Services
$33.34
Up+$0.14 (+0.42%)
Updated Nov 14, 2026, 5:42 AM
SID Score
4.5/10
Composite research score
Smart Money
58/100
Neutral
Price performance · DOCS
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
DOCS closed at $33.34 after 21 trading sessions, up 7.65% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $33.51 | $33.705 | $32.79 | $33.34 | 1.4M |
| Nov 12, 2026 | $32.965 | $33.89 | $32.82 | $33.20 | 1.95M |
| Nov 11, 2026 | $32.36 | $33.63 | $31.96 | $33.22 | 2.28M |
| Nov 10, 2026 | $32.49 | $32.79 | $31.87 | $32.42 | 2.13M |
| Nov 9, 2026 | $32.24 | $33.09 | $31.90 | $32.87 | 3.07M |
| Nov 6, 2026 | $30.26 | $32.62 | $29.80 | $32.51 | 4.29M |
| Nov 5, 2026 | $34.76 | $35.15 | $32.96 | $33.18 | 2.66M |
| Nov 4, 2026 | $33.10 | $34.92 | $32.915 | $34.67 | 3M |
| Nov 3, 2026 | $32.38 | $33.08 | $31.93 | $32.60 | 2.15M |
| Nov 2, 2026 | $32.89 | $33.735 | $32.80 | $32.87 | 1.77M |
| Oct 30, 2026 | $33.48 | $33.885 | $32.49 | $32.76 | 2.2M |
| Oct 29, 2026 | $33.94 | $34.80 | $33.58 | $33.63 | 2.73M |
| Oct 28, 2026 | $32.74 | $34.25 | $32.6776 | $34.25 | 2M |
| Oct 27, 2026 | $33.00 | $33.25 | $32.44 | $33.24 | 2.01M |
| Oct 26, 2026 | $33.30 | $33.99 | $32.85 | $33.08 | 2.25M |
| Oct 23, 2026 | $33.55 | $33.80 | $33.215 | $33.39 | 1.59M |
| Oct 22, 2026 | $33.58 | $34.155 | $33.37 | $33.68 | 2.85M |
| Oct 21, 2026 | $33.04 | $34.275 | $33.04 | $33.58 | 2.9M |
| Oct 20, 2026 | $31.96 | $34.10 | $31.82 | $33.35 | 4.36M |
| Oct 19, 2026 | $30.80 | $31.57 | $30.59 | $31.45 | 2.03M |
| Oct 16, 2026 | $31.97 | $32.11 | $30.59 | $30.97 | 3.58M |
The latest Smart Investors Daily articles mentioning DOCS.
Company
Market Activity
Research & News
DOCS research
Company profile and research snapshot.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 11, 2026 | Barclays | Equal-Weight | — |
| Nov 10, 2026 | Freedom Capital Markets | Hold | — |
| Nov 6, 2026 | RBC Capital | Outperform | — |
| Nov 6, 2026 | Canaccord Genuity | Buy | — |
| Nov 6, 2026 | Evercore ISI Group | In-Line | — |
No generated briefing is available yet.
Yahoo · Nov 7, 2026
Doximity (NYSE:DOCS) reported fiscal second-quarter revenue growth of 4% and raised its full-year outlook, as expanding use of its artificial intelligence tools and improving AI cost efficiency helped the company exceed its guidance. Revenue was $174.5 million for the quarter, while adjusted earnin
Yahoo · Nov 6, 2026
Investing.com -- Doximity Inc (DOCS) beat on the top line but lost ground on profitability. It trades at $31.87 (-3.95%) as of Nov 6, 12:51 PM EST. It had touched $30.44 pre-market at 9:28 AM EST, so it has recovered part of the early drop.
SeekingAlpha · Nov 6, 2026
Doximity, Inc. (DOCS) Q2 2027 Earnings Call November 5, 2026 5:00 PM ESTCompany ParticipantsPerry Gold - Head of Investor RelationsJeffrey Tangney -...
Benzinga · Nov 6, 2026
Canaccord Genuity analyst Richard Close maintains Doximity (NYSE:DOCS) with a Buy and raises the price target from $36 to $40.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning DOCS.
